PEAK PERFORMANCEMonths to result

Glucose Subphenotyping Framework

Personalized glucose management

Problem it solves

Decision-makers who lack a structured approach to evaluate glucose subphenotyping framework-related choices, leading to inconsistent or suboptimal outcomes.

Best for

Individuals with glucose dysregulation or insulin resistance

Not ideal for

Those without access to glucose monitoring or subphenotyping tests

Overview

Why this framework exists

The Glucose Subphenotyping Framework involves identifying an individual's unique glucose dysregulation subtype to inform personalized lifestyle and treatment decisions. This approach recognizes that different subtypes respond differently to various foods, exercises, and medications. By understanding one's subphenotype, individuals can make targeted changes to improve their glucose control and overall health.

Core principles

3 total
  1. Glucose dysregulation is a heterogeneous condition with multiple subtypes.
  2. Each subtype responds differently to various lifestyle and treatment interventions.
  3. Personalized approaches to glucose management can lead to improved health outcomes.

Steps

3 steps
  1. Determine Glucose Subphenotype
    Undergo testing to determine individual glucose subphenotype, such as muscle insulin resistant or beta cell defect.
    Pro tipUtilize continuous glucose monitoring (CGM) or other advanced testing methods for accurate subphenotyping.
    WarningInaccurate subphenotyping may lead to ineffective treatment or lifestyle changes.
  2. Tailor Lifestyle Interventions
    Based on subphenotype, make targeted changes to diet, exercise, and other lifestyle factors to improve glucose control.
    Pro tipWork with a healthcare professional to develop a personalized plan.
    WarningFailure to tailor interventions to individual subphenotype may lead to poor health outcomes.
  3. Select Appropriate Medications
    Choose medications that are effective for the individual's specific subphenotype, such as repaglinide for beta cell defects.
    Pro tipConsult with a healthcare professional to determine the best medication regimen.
    WarningInappropriate medication selection may lead to adverse effects or poor glucose control.

Checklist

Saved in your browser

Examples

1 cases
Case Study: Dr. Michael Snyder

Dr. Snyder, a beta cell defect subtype, experienced improved glucose control after initiating repaglinide and making targeted lifestyle changes.

OutcomeSignificant reduction in hemoglobin A1C levels and improved overall health.

Common mistakes

2 traps
Failure to Account for Subphenotype
Neglecting to consider an individual's unique glucose subphenotype may lead to ineffective treatment or lifestyle changes.
Inaccurate Subphenotyping
Incorrect subphenotyping may result in poor health outcomes due to inappropriate lifestyle or treatment interventions.

Origin story

How this framework came to be

Dr. Michael Snyder's work on glucose subphenotyping has led to the development of this framework, which aims to provide a more nuanced understanding of glucose dysregulation and its treatment.

Source

Traced to primary
Source · PODCAST
Transform Your Metabolic Health & Longevity by Knowing Your Unique Biology | Dr. Michael Snyder
Andrew Huberman · 2025
Open source →